Attributes | Values |
---|
rdf:type
| |
Description
| - Angiotensin II receptor blockers are often used to treat hypertension. In addition, certain molecules such as telmisartan have a strong impact on fat cell volume and fat accumulation, as well as distinctive effects on energy metabolism, that may help protect against visceral obesity
- Angiotensin II receptor blockers are often used to treat hypertension. In addition, certain molecules such as telmisartan have a strong impact on fat cell volume and fat accumulation, as well as distinctive effects on energy metabolism, that may help protect against visceral obesity (en)
- Blokátory receptorů pro angiotensin II se často používají k léčbě hypertenze. Kromě toho bylo zjištěno, že některé blokátory, jako telmisartan, významně ovlivňují velikost adipocytů a akumulaci tuku a navíc účinně zvyšují energetický metabolizmus, což je významné pro prevenci obezity (cs)
|
Title
| - Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis
- Telmisartan, ale ne valsartan zvyšuje kalorický výdej a chrání před obezitou a jaterní steatózou (cs)
- Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis (en)
|
skos:prefLabel
| - Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis
- Telmisartan, ale ne valsartan zvyšuje kalorický výdej a chrání před obezitou a jaterní steatózou (cs)
- Telmisartan but not valsartan increases caloric expenditure and protects against weight gain and hepatic steatosis (en)
|
skos:notation
| - RIV/67985823:_____/06:00039169!RIV07-MZ0-67985823
|
http://linked.open.../vavai/riv/strany
| |
http://linked.open...avai/riv/aktivita
| |
http://linked.open...avai/riv/aktivity
| - P(1M0520), P(NR8495), Z(AV0Z50110509)
|
http://linked.open...iv/cisloPeriodika
| |
http://linked.open...vai/riv/dodaniDat
| |
http://linked.open...aciTvurceVysledku
| |
http://linked.open.../riv/druhVysledku
| |
http://linked.open...iv/duvernostUdaju
| |
http://linked.open...titaPredkladatele
| |
http://linked.open...dnocenehoVysledku
| |
http://linked.open...ai/riv/idVysledku
| - RIV/67985823:_____/06:00039169
|
http://linked.open...riv/jazykVysledku
| |
http://linked.open.../riv/klicovaSlova
| - hypertension; obesity; angiotensin II receptors (en)
|
http://linked.open.../riv/klicoveSlovo
| |
http://linked.open...odStatuVydavatele
| - US - Spojené státy americké
|
http://linked.open...ontrolniKodProRIV
| |
http://linked.open...i/riv/nazevZdroje
| |
http://linked.open...in/vavai/riv/obor
| |
http://linked.open...ichTvurcuVysledku
| |
http://linked.open...cetTvurcuVysledku
| |
http://linked.open...vavai/riv/projekt
| |
http://linked.open...UplatneniVysledku
| |
http://linked.open...v/svazekPeriodika
| |
http://linked.open...iv/tvurceVysledku
| - Kazdová, L.
- Kurtz, T. W.
- Pravenec, Michal
- Sugimoto, K.
- Qi, N. R.
- Ogihara, T.
|
http://linked.open...n/vavai/riv/zamer
| |
issn
| |
number of pages
| |
is http://linked.open...avai/riv/vysledek
of | |